Mode
Text Size
Log in / Sign up
N/A N=262 Randomized Triple-blind Supportive Care

Computerized PAINRelieveIt Protocol for Cancer Pain Control in Hospice

Cancer · Pain

Enrolled (actual)
262
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Analgesic Adherence-patient — 0.66; 0.67 proportion (0-1), higher is better — p=.43

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PAINReportIt (Behavioral); PAINConsultN (Behavioral); PAINUCope (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Illinois at Chicago
Primary completion
Sep 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Analgesic Adherence-patient
0.66; 0.67 .43
SECONDARY
Worst Pain Intensity-patient
6.05; 6.63 .02 sig

Summary

The study purpose is to compare usual hospice care and PAINRelieveIt groups for effects on: (1) patient outcomes (analgesic adherence; worst pain intensity, satisfaction, and misconceptions) and lay caregiver outcome (pain misconceptions) in a diverse sample of 250 cancer patient-caregiver dyads receiving hospice care; and (2) nurse outcomes (obtained appropriate analgesics for patient) in a sample of hospice nurses. The investigators hypothesize that at posttest, controlling for pretest data and compared to the usual care group, the PAINRelieveIt group will: a) report decreased scores for worst pain intensity and pain misconceptions; b) have increased analgesic adherence (primary outcome); and c) have a larger proportion who report satisfaction with pain intensity and whose nurses obtained appropriate analgesics for the patients' pain.

Eligibility Criteria

Inclusion Criteria

Study inclusion criteria require that the patient: (1) be admitted to home care level of hospice service; (2) has a diagnosis of cancer; (3) has experienced worst pain in the past 24 hours >3 on a 0-10 scale; (4) speaks, reads and writes English, Spanish, or Chinese; (5) is > 18 years of age; 6) has a lay caregiver who is > 18 years of age and willing to participate; and (7) has a life expectancy of about 19 days at the time of study enrollment, as suggested by a Palliative Performance Scale (PPS)41 score of > 40.

The lay caregiver inclusion criteria require that the individual: (1) be designated as the primary lay caregiver for the participating patient during the 7-day study period; (2) speaks, reads and writes English, Spanish, or Chinese; and (3) is > 18 years of age.

The hospice nurse inclusion criteria require that the individual: (1) be assigned as the primary hospice nurse for the participating patient during the 7-day study period; (2) speaks, reads and writes English (since the PAINConsultN is in English) but may speak Spanish or Chinese for clinical care purposes; and (3) is > 18 years of age.

Exclusion Criteria

  • Patients and lay caregivers will be excluded if they: (1) are legally blind or deaf; or (2) have cognitive or physical impairments making it impossible to communicate or to complete study instruments at enrollment or any time during the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02026115). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search